Northwest Biotherapeutics Owners

Health Care & Life Sciences » Biotechnology | Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Woodford Investment Management Ltd.

24,815,028

5.54%

6,498,349

0.04%

12/31/2017

Sabby Capital LLC

15,761,350

3.52%

-6,792,309

1.7%

12/31/2017

Invesco Capital Management LLC

101,001

0.02%

09/05/2018

WhaleRock Point Partners LLC

30,000

0.01%

10,000

03/31/2018

Lee, Danner & Bass, Inc.

20,000

06/30/2018

Heights Capital Management, Inc.

-8,237,545

12/31/2017

View Profile

Address	4800 Montgomery Lane Bethesda Maryland 20814 United States
Employees	-
Website	http://www.nwbio.com
Updated	07/08/2019
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines.